On 30 May 2013, the Annual General Meeting called for an Extraordinary General Meeting to be held in Hofseth BioCare ASA.
All the proposed resolutions in the Annual General Meeting on the 30th of May were approved, except issue 4; "Approval of the annual accounts and annual report for 2012, as well as cover of loss." Some issues regarding the final audit were not finalized and the AGM decided to call for an Extraordinary General Meeting to approve the annual accounts.
Enclosed the notice of the Extraordinary General Meeting to be held on June 21st 2013.
For further information, please contact:
Jon Olav Ødegård, CEO Hofseth BioCare ASA
Tel: +47 936 32 966
E-mail: joo@h-bc.no
About Hofseth BioCare:
Hofseth BioCare is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology and logistics, Hofseth BioCare is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. Products that previously could only be used as animal feed can now be made suitable for human consumption. HBCs objective is thus to contribute to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
